Invention Grant
- Patent Title: Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
-
Application No.: US16841026Application Date: 2020-04-06
-
Publication No.: US10993932B2Publication Date: 2021-05-04
- Inventor: William H. Pitlick , Alan R. Meyer , Mina Sooch , Konstantinos Charizanis , Bernhard Hoffmann
- Applicant: Ocuphire Pharma, Inc.
- Applicant Address: US MI West Bloomfield
- Assignee: Ocuphire Pharma, Inc.
- Current Assignee: Ocuphire Pharma, Inc.
- Current Assignee Address: US MI West Bloomfield
- Agency: Dechert LLP
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/417 ; A61P27/08 ; A61P27/10 ; A61K31/4178 ; A61K9/00 ; A61K9/08 ; A61K47/12 ; A61K47/26
Abstract:
The invention provides methods, compositions, and kits containing an alpha-adrenergic antagonist, such as phentolamine, for use in monotherapy or as part of a combination therapy to treat patients suffering from presbyopia, mydriasis, and/or other ocular disorders.
Public/Granted literature
- US20200253931A1 METHODS AND COMPOSITIONS FOR TREATMENT OF PRESBYOPIA, MYDRIASIS, AND OTHER OCULAR DISORDERS Public/Granted day:2020-08-13
Information query
